Werner Kroll - 28 Jul 2022 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Aug 2022, 19:16:33 UTC
Prior SEC filing
06 Jul 2022
Next SEC filing
02 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip S. Askim, attorney-in-fact for Werner Kroll

Key filing fact

Werner Kroll filed Form 4 for QuidelOrtho Corp (QDEL) on 01 Aug 2022.

Key facts

  • This page summarizes Werner Kroll's Form 4 filing for QuidelOrtho Corp (QDEL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 01 Aug 2022, 19:16.

Change

  • Previous filing in this sequence was filed on 06 Jul 2022.
  • Current net transaction value: -$59,477.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Award

Transaction value
$0
Shares
+1,170
Change %
+6.1%
Price
$0.000000
Shares after
20,427
Date
28 Jul 2022
Ownership
Direct
Footnotes
F1
QDEL transaction

Common Stock

Tax liability

Transaction value
$59,477
Shares
-581
Change %
-2.8%
Price
$102.37
Shares after
19,846
Date
28 Jul 2022
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,170
Change %
-33%
Price
$0.000000
Shares after
2,340
Date
28 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,170
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects release of restricted stock units that were previously reported on a Form 4.

Footnote F2

Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

Footnote F3

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F4

1,170 shares vested on 7/28/2022 and 2,340 shares will vest in equal installments on July 28, 2023 and July 28, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .